Jaebong JANG

Person

Brookline, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of EGFR and methods of use thereof
- Patent number 12,161,649
- Issue date Dec 10, 2024
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of EGFR and/or HER2 and methods of use
- Patent number 11,945,816
- Issue date Apr 2, 2024
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyano quinoline amide compounds as HER2 inhibitors and methods of use
- Patent number 11,814,379
- Issue date Nov 14, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidines as EGFR inhibitors and methods of treating disorders
- Patent number 11,673,882
- Issue date Jun 13, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of EGFR and methods of use thereof
- Patent number 11,584,746
- Issue date Feb 21, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of EGFR and/or HER2 and methods of use
- Patent number 11,186,574
- Issue date Nov 30, 2021
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional molecules for degradation of EGFR and methods of use
- Patent number 11,161,842
- Issue date Nov 2, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidines as EGFR inhibitors and methods of treating disorders
- Patent number 10,870,636
- Issue date Dec 22, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of EGFR and methods of use thereof
- Patent number 10,836,722
- Issue date Nov 17, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidines as EGFR inhibitors and methods of treating disorders
- Patent number 10,550,112
- Issue date Feb 4, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional molecules for degradation of EGFR and methods of use
- Patent number 10,450,310
- Issue date Oct 22, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of EGFR and methods of use thereof
- Patent number 10,385,019
- Issue date Aug 20, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidines as EGFR inhibitors and methods of treating disorders
- Patent number 10,266,517
- Issue date Apr 23, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL PYRIMIDINES AS EGFR-INHIBITORS AND METHODS OF TREATING DISORDERS
- Publication number 20230348434
- Publication date Nov 2, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE
- Publication number 20220106310
- Publication date Apr 7, 2022
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE
- Publication number 20220017510
- Publication date Jan 20, 2022
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYANO QUINOLINE AMIDE COMPOUNDS AS HER2 INHIBITORS AND METHODS OF USE
- Publication number 20210355119
- Publication date Nov 18, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20210346395
- Publication date Nov 11, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20210094913
- Publication date Apr 1, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS OF EGFR INHIBITORS AND METHODS OF USE T...
- Publication number 20210085688
- Publication date Mar 25, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS OF EGFR INHIBITORS AND METHODS OF USE T...
- Publication number 20210077469
- Publication date Mar 18, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
- Publication number 20210078977
- Publication date Mar 18, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20210040088
- Publication date Feb 11, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20200390783
- Publication date Dec 17, 2020
- NATHANAEL S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEGRADERS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20200377501
- Publication date Dec 3, 2020
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMBINATIONS OF EGFR INHIBITORS AND METHODS OF USE T...
- Publication number 20200375999
- Publication date Dec 3, 2020
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEGRADERS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20200377477
- Publication date Dec 3, 2020
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL MOLECULES FOR HER3 DEGRADATION AND METHODS OF USE
- Publication number 20200216454
- Publication date Jul 9, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE
- Publication number 20200199121
- Publication date Jun 25, 2020
- Dana-Farber Cancer Institute, Inc.
- JOHN M. HATCHER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE
- Publication number 20200102298
- Publication date Apr 2, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20200002279
- Publication date Jan 2, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
- Publication number 20190194169
- Publication date Jun 27, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE
- Publication number 20190106417
- Publication date Apr 11, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR HER3 DEGRADATION AND METHODS OF USE
- Publication number 20190016703
- Publication date Jan 17, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20180290975
- Publication date Oct 11, 2018
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
- Publication number 20180194758
- Publication date Jul 12, 2018
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
- Publication number 20170362204
- Publication date Dec 21, 2017
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY

Jaebong JANG

Person

Patents Grantslast 30 patents

Inhibitors of EGFR and methods of use thereof

Inhibitors of EGFR and/or HER2 and methods of use

Cyano quinoline amide compounds as HER2 inhibitors and methods of use

Pyrimidines as EGFR inhibitors and methods of treating disorders

Inhibitors of EGFR and methods of use thereof

Inhibitors of EGFR and/or HER2 and methods of use

Bifunctional molecules for degradation of EGFR and methods of use

Pyrimidines as EGFR inhibitors and methods of treating disorders

Inhibitors of EGFR and methods of use thereof

Pyrimidines as EGFR inhibitors and methods of treating disorders

Bifunctional molecules for degradation of EGFR and methods of use

Inhibitors of EGFR and methods of use thereof

Pyrimidines as EGFR inhibitors and methods of treating disorders

Patents Applicationslast 30 patents

NOVEL PYRIMIDINES AS EGFR-INHIBITORS AND METHODS OF TREATING DISORDERS

INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE

BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE

CYANO QUINOLINE AMIDE COMPOUNDS AS HER2 INHIBITORS AND METHODS OF USE

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

PHARMACEUTICAL COMBINATIONS OF EGFR INHIBITORS AND METHODS OF USE T...

PHARMACEUTICAL COMBINATIONS OF EGFR INHIBITORS AND METHODS OF USE T...

NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

DEGRADERS OF EGFR AND METHODS OF USE THEREOF

PHARMACEUTICAL COMBINATIONS OF EGFR INHIBITORS AND METHODS OF USE T...

DEGRADERS OF EGFR AND METHODS OF USE THEREOF

BIFUNCTIONAL MOLECULES FOR HER3 DEGRADATION AND METHODS OF USE

INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE

BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS

BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE

BIFUNCTIONAL COMPOUNDS FOR HER3 DEGRADATION AND METHODS OF USE

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS

NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS